Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > P2 TH1902
View:
Post by TH1902 on Sep 12, 2022 6:04pm

P2 TH1902

Where does a move into Phase 2 take the share price?  And how soon could that happen?

Was tempted to add today, lets see if we get continuation of this move in the coming days, seems we are on nobody's radar or very few.
Comment by SPCEO1 on Sep 12, 2022 9:17pm
First, it is worth remembering that almost every drug trial for every commpany takes longer than initally expected, or so it seems.  My best guess as the timing we would all hope to see goes something like this. Tomorrow, or sometime soon, we get a PR telling us they are applying for a protocol expansion in one cancer type, let's say ovarian for arguments sake and since ovarian was one ...more  
Comment by Wino115 on Sep 13, 2022 12:26pm
Analysis from looking at the IMMU movement and then later looking at around 6 other instances of a companies first cancer indication approval (some were ADCs, some weren't) showed a roughly 5x stock movement in the Phase 1 and through Phase 2.  Then phase 2 into phase 3 saw another 4x for those that got approved (in this case they were all approved) .  The latest takeover multiple on ...more  
Comment by TH1902 on Sep 13, 2022 9:28pm
Excellent, thank you both. Wild to think that Thera is under $300M MC, we need more eyes and some more good cancer news...hopeful for some exciting days ahead
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities